These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 19183154)
1. Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis. Kane SV; Accortt NA; Magowan S; Brixner D Aliment Pharmacol Ther; 2009 Apr; 29(8):855-62. PubMed ID: 19183154 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Kane SV; Cohen RD; Aikens JE; Hanauer SB Am J Gastroenterol; 2001 Oct; 96(10):2929-33. PubMed ID: 11693328 [TBL] [Abstract][Full Text] [Related]
3. An investigation of medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis, using self-report and urinary drug excretion measurements. Moshkovska T; Stone MA; Clatworthy J; Smith RM; Bankart J; Baker R; Wang J; Horne R; Mayberry JF Aliment Pharmacol Ther; 2009 Dec; 30(11-12):1118-27. PubMed ID: 19785623 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of olsalazine (dipentum) in the treatment of patients with ulcerative colitis--results of a field study. Singer MV; Schmausser H; Schönfeld G Hepatogastroenterology; 2006; 53(69):317-21. PubMed ID: 16795963 [TBL] [Abstract][Full Text] [Related]
5. Medication use patterns and predictors of nonpersistence and nonadherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis. Yen L; Wu J; Hodgkins PL; Cohen RD; Nichol MB J Manag Care Pharm; 2012; 18(9):701-12. PubMed ID: 23206213 [TBL] [Abstract][Full Text] [Related]
6. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction. Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916 [TBL] [Abstract][Full Text] [Related]
7. [Adherence to antihypertensive and lipid-lowering medications: a problem of public health, not yet resolved]. Grosso G; Raciti T; Marventano S; Romeo I; Mistretta A Ann Ig; 2011; 23(2):173-84. PubMed ID: 21770233 [TBL] [Abstract][Full Text] [Related]
8. Review article: new drug formulations, chemical entities and therapeutic approaches for the management of ulcerative colitis. Ng SC; Kamm MA Aliment Pharmacol Ther; 2008 Oct; 28(7):815-29. PubMed ID: 18627362 [TBL] [Abstract][Full Text] [Related]
9. Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006). Yamamoto-Furusho JK J Clin Gastroenterol; 2009 Mar; 43(3):221-4. PubMed ID: 19057395 [TBL] [Abstract][Full Text] [Related]
10. [Characterization of proteinuria in patients with ulcerative colitis and therapy with aminosalicylates]. Buschhausen L; Kruis W; Aymaz S; Weber M; Krakamp B Med Klin (Munich); 2006 Oct; 101(10):791-5. PubMed ID: 17039321 [TBL] [Abstract][Full Text] [Related]
11. Long-term oral mesalazine adherence and the risk of disease flare in ulcerative colitis: nationwide 10-year retrospective cohort from the veterans affairs healthcare system. Khan N; Abbas AM; Bazzano LA; Koleva YN; Krousel-Wood M Aliment Pharmacol Ther; 2012 Oct; 36(8):755-64. PubMed ID: 22882428 [TBL] [Abstract][Full Text] [Related]
12. Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis. Mitra D; Hodgkins P; Yen L; Davis KL; Cohen RD BMC Gastroenterol; 2012 Sep; 12():132. PubMed ID: 23006789 [TBL] [Abstract][Full Text] [Related]
13. 5-Aminosalicylic acid in pregnancy: clinical report. Trallori G; d'Albasio G; Bardazzi G; Bonanomi AG; Amorosi A; Del Carlo P; Palli D; Galli M; Pacini F Ital J Gastroenterol; 1994 Mar; 26(2):75-8. PubMed ID: 8032081 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitis. Yen EF; Kane SV; Ladabaum U Am J Gastroenterol; 2008 Dec; 103(12):3094-105. PubMed ID: 18775007 [TBL] [Abstract][Full Text] [Related]
15. Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy. Iaquinto G; Sorrentini I; Petillo FE; Berardesca G Ital J Gastroenterol; 1994 Apr; 26(3):145-7. PubMed ID: 8061342 [TBL] [Abstract][Full Text] [Related]
16. Performance of compliance and persistence measures in predicting clinical and economic outcomes using administrative data from German sickness funds. Frey S; Stargardt T Pharmacotherapy; 2012 Oct; 32(10):880-9. PubMed ID: 23033227 [TBL] [Abstract][Full Text] [Related]
17. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients. Cheong C; Barner JC; Lawson KA; Johnsrud MT Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846 [TBL] [Abstract][Full Text] [Related]
18. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal. Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172 [TBL] [Abstract][Full Text] [Related]
19. Ulcerative colitis: current medical therapy and strategies for improving medication adherence. Zhang Z; Kennedy H Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):1-8. PubMed ID: 19011573 [TBL] [Abstract][Full Text] [Related]
20. Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension. Robertson TA; Cooke CE; Wang J; Shaya FT; Lee HY Am J Manag Care; 2008 Nov; 14(11):710-6. PubMed ID: 18999905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]